All In MedTech

FDA Clearance Tracker · P100045-S053

CardioMEMS HF System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 10, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 10, 2021

Approved

Time to decision

119 days

Received Apr 13, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100045-S053
Device name
CardioMEMS HF System
Applicant location
Atlanta, GA
Received
Apr 13, 2021
Decided
Aug 10, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P100045

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MOM

FDA's approval statement

As written in FDA's record.

Approval for device use and implantation through an internal jugular vein access site.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.